Scientific focus: Genome-engineering and Neurodegeneration
Curriculum vitae and Publications
Phone: +49 7071 29 82975
Fax: +49 7071 29 4451
My research interest focuses on the use of CRISPR-Cas9 genome editing technologies to modulate and define the functions of genes playing a key role in neurodegenerative diseases. Therefore, coupling gene-engineering tools with in vivo imaging methodologies, especially PET and fMRI, represents my goal to gain concurrent and complementary information of changes in functional connectivity in different brain regions at early to late stages of the diseases.